Log in

Entwicklung komplexer Screening verfahren am Beispiel von Hsp90

  • Wissenschaft · Special: Laborautomation
  • Target-Omics
  • Published:
BIOspektrum Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The protein target-microarray assay is a hitherto underestimated method in the investigation of protein-ligand/inhibitor and protein-protein/inhibitor-interactions. It is a versatile and adaptable method that can also be used in the diagnostic and individual medicine. Following, examples for target-oriented tests with high potential for development are demonstrated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Lindquist S (1986) The heat shock response. Annu Rev Biochem 55:1151–1191

    Article  CAS  PubMed  Google Scholar 

  2. Doyle SM, Genest O, Wickner S (2013) Protein rescue from aggregates by powerful molecular chaperone machines. Nat Rev Mol Cell Biol 14:617–629

    Article  CAS  PubMed  Google Scholar 

  3. Trepel J, Mollapour M, Giaccone G et al. (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537–549

    Article  CAS  PubMed  Google Scholar 

  4. Kirschning A, Walter JG, Stahl F et al. (2015) Molecular survival strategies of organisms: HSP and small molecules for diagnostics and drug development. In: Asea AAA, Almasoud NN, Krishnan S et al. (Hrsg) Heat Shock Proteins-Based Therapies, Vol 8. Springer, Cham, S 323–344

    Chapter  Google Scholar 

  5. Franke J, Eichner S, Zeilinger C et al. (2013) Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy. Nat Prod Rep 30:1299–1323

    Article  CAS  PubMed  Google Scholar 

  6. Eichner S, Eichner T, Floss HG et al. (2012) Broad substrate specificity of the amide synthase in S. hygroscopicus–new 20-membered macrolactones derived from geldanamycin. J Am Chem Soc 134:1673–1679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Schax E, Walter JG, Märzhäuser H et al. (2014) Microarray-based screening of heat shock protein inhibitors. J Biotechnol 180:1–9

    Article  CAS  PubMed  Google Scholar 

  8. Hermane J, Bułyszko I, Eichner S et al. (2015) New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90. Chembiochem 16:302–311

    Article  CAS  PubMed  Google Scholar 

  9. Sharma R, Mohammadi-Ostad-Kalayeh S, Stahl F et al. (2017) Two new labdane diterpenoids and one new β lactam compound from the aerial part of Roylea cinerea. Phytochem Lett 19:101–107

    Article  CAS  Google Scholar 

  10. Schax E, Neunaber J, Stahl F et al. (2014) Multiplexed heat shock protein microarray as a screening platform for the selection of novel drug compounds. Biodiscovery 14:1–6

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Stahl.

Additional information

Sabine Helmsen 2016 Bachelorabschluss in Chemie an der Universität Hannover. Derzeit Masterarbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikroarrays, Masterstudiengang Analytik.

Vjaceslavs Hrupins 20112014 Bachelorstudium Biochemie und 20142016 Masterstudium Wirk- und Naturstoffchemie an der Universität Hannover. Master arbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikroarrays. Zurzeit Promotion bei Prof. Dr. R. J. Cox.

Christin Ahlbrecht 20112017 Studium Life Science an der Universität Hannover. Masterarbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikro arrays. Zurzeit Promotion bei Prof. Dr. O. Plettenburg.

Frank Stahl Biologiestudium an der Universität Gießen, dort 1998 Promotion bei Prof. Dr. A. **oud am Institut für Biochemie. Postdoc an der Gesellschaft für Biotechnologische Forschung mbh (GBF), Braunschweig. Danach Labormanager, Genedrugs GmbH, Hechingen. Seit 2003 Arbeitsgruppenleiter Chiptechnologien am Institut für Technische Chemie der Universität Hannover.

Carsten Zeilinger Biologiestudium an der Universität Osnabrück, dort 1990 Promotion bei Prof. Dr. E. W. Weiler am Lehrstuhl Pflanzenphysiologie. 1998 Habilitation in Pflanzenphysiologie an der Universität Hannover. Seit 2008 Arbeitsgruppenleiter am Biomolekularen Wirkstoffzentrum (BMWZ), Hannover.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Helmsen, S., Ahlbrecht, C., Hrupins, V. et al. Entwicklung komplexer Screening verfahren am Beispiel von Hsp90. Biospektrum 23, 540–543 (2017). https://doi.org/10.1007/s12268-017-0839-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-017-0839-8

Navigation